Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?

BACKGROUND: Administration of onabotulinumtoxinA (BoNT-A) to peripheral tissues outside the calvaria reduces the number of days chronic migraine patients experience headache. Because the headache phase of a migraine attack, especially those preceded by aura, is thought to involve activation of menin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, XiChun, Strassman, Andrew M, Novack, Victor, Brin, Mitchell F, Burstein, Rami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959034/
https://www.ncbi.nlm.nih.gov/pubmed/26984967
http://dx.doi.org/10.1177/0333102416636843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959034/
https://www.ncbi.nlm.nih.gov/pubmed/26984967
http://dx.doi.org/10.1177/0333102416636843

Ejemplares similares